Nasdaq GlobeNewswire

Inspirata Announces Web-Enabled Version of Dynamyx™ Digital Pathology Software

Del

Version 2.0.7 of Dynamyx eases internal and external collaboration, provides multi-language localization and supports the ingestion of a wide range of scanner image formats.

Tampa, FL, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology workflow solution provider Inspirata®, Inc. announced today that Dynamyx v 2.0.5 has been released with an array of new features to help pathologists work more efficiently, openly and collaboratively.

The latest release of the Omnyx Dynamyx software is Web-based, leveraging HTML5 technology to enable pathologists to collaborate between care teams regardless of location. This “anywhere/anytime access” includes reviewing cases, images and worklists remotely from a compatible browser without having to download an additional application; sharing case files with varying permission levels within an institution as well as with outside pathologists for second opinions; and engaging seamlessly with research colleagues.

Multi-language localization also is available. Language options include English, German, Spanish and Portuguese to address the needs of Inspirata’s customers around the world. Additionally, in keeping with Inspirata’s scanner-agnostic philosophy, Dynamyx 2.0.7 can ingest bright-field images from the 3DHistech, Aperio/Leica, Hamamatsu, Philips and others.

“Dynamyx is more powerful than ever,” says Inspirata General Manager, Digital Pathology, Andrew Chomos. “It’s critical that digital pathology workflow solutions are open, collaborative and flexible to provide the highest level of utility to our pathologist community. We are proud of the ways this Dynamyx release achieves all of these criteria, making it easy for pathologists to reap the tangible benefits of digital pathology.”

Additional new features in Dynamyx 2.0.7 include expanded annotations and visual indicators to help a pathologist view case details at a glance. The installed client of Dynamyx 2.0.7 is compatible with Windows 10 and an update was made to the deployment pipeline eliminating the need to deploy from an external server external.

“We have invested heavily to ensure the new Dynamyx software seamlessly supports pathologists’ workflow and enables them to be as efficient as possible at diagnosing disease,” says Inspirata EVP and Founder Mark Lloyd. “This new software release offers market-leading advantages that are simply not available in any other digital pathology workflow solution.”

About Inspirata, Inc.

Inspirata®, Inc. provides oncology diagnostics workflow solutions that span digital pathology; diagnostic and predictive assays; and precision medicine. It also offers cancer informatics workflows that, in combination with its Natural Language Processing (NLP) and Artificial Intelligence (AI) algorithms structures unstructured case files and clinician notes to provide key insights for oncology-specific clinical and operational activities as well as cancer reporting. Inspirata’s flagship solution is its Cancer Information Data Trust (CIDT) that generates a longitudinal view of oncology patients—from diagnosis, through treatments and therapies, to outcomes. The CIDT has extensive applications in clinical decision support, research, education, drug discovery and clinical trials enrollment. Its use will extend to physicians, patients, researchers, pharma and others. For more information, please visit www.inspirata.com or contact info@inspirata.com.

Attachment

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Lehman Brothers UK Capital Funding V LP: Notice to the Holders of the Preferred Securities19.11.2018 18:03Pressemelding

LONDON, Nov. 19, 2018 (GLOBE NEWSWIRE) -- TEMP: 91SI NOTICE TO THE HOLDERS OF: USD 500,000,000 FIXED RATE ENHANCED CAPITAL ADVANTAGED PREFERRED SECURITIES ("LP V ECAPS") ISSUER: LEHMAN BROTHERS UK CAPITAL FUNDING V LP ("LP V") ISIN: XS0301813522 LIQUIDATION OF LB GP NO.1 LTD ("the Company") AND IMPLICATIONS FOR HOLDERS OF LP V ECAPS THIS NOTICE CONTAINS IMPORTANT INFORMATION THAT IS OF INTEREST TO THE REGISTERED AND BENEFICIAL OWNERS OF THE SUBJECT SECURITIES. IF APPLICABLE, ALL DEPOSITORIES, CUSTODIANS AND OTHER INTERMEDIARIES RECEIVING THIS NOTICE ARE REQUESTED TO EXPEDITE THE RE-TRANSMITTAL TO BENEFICIAL OWNERS OF THE SECURITIES IN A TIMELY MANNER. Your attention is drawn to the formal notice contained in the PDF link below concerning the Company, LP V and the LP V ECAPS. In order to view the formal notice, it is recommended that you copy and paste the link into your browser. http://www.rns-pdf.londonstockexchange.com/rns/8119H_1-2018-11-19.pdf If you have any difficulties in openin

Lehman Brothers UK Capital Funding LP: Notice to the Holders of the Preferred Securities19.11.2018 17:53Pressemelding

LONDON, Nov. 19, 2018 (GLOBE NEWSWIRE) -- NOTICE TO THE HOLDERS OF: EUR 225,000,000 FIXED RATE TO CMS-LINKED GUARANTEED NON-VOTING, NON-CUMULATIVE PERPETUAL PREFERRED SECURITIES ("LP I Securities") ISSUER: LEHMAN BROTHERS UK CAPITAL FUNDING LP ("LP I") ISIN: XS0215349357 LIQUIDATION OF LB GP NO.1 LTD ("the Company") AND IMPLICATIONS FOR HOLDERS OF LP I SECURITIES THIS NOTICE CONTAINS IMPORTANT INFORMATION THAT IS OF INTEREST TO THE REGISTERED AND BENEFICIAL OWNERS OF THE SUBJECT SECURITIES. IF APPLICABLE, ALL DEPOSITORIES, CUSTODIANS AND OTHER INTERMEDIARIES RECEIVING THIS NOTICE ARE REQUESTED TO EXPEDITE THE RE-TRANSMITTAL TO BENEFICIAL OWNERS OF THE SECURITIES IN A TIMELY MANNER. Your attention is drawn to the formal notice contained in the PDF link below concerning the Company, LP I and the LP I Securities. In order to view the formal notice, it is recommended that you copy and paste the link into your browser. http://www.rns-pdf.londonstockexchange.com/rns/8123H_1-2018-11-19.pdf If

Lehman Brothers UK Capital Funding IV LP: Notice to the Holders of the Preferred Securities19.11.2018 17:46Pressemelding

LONDON, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Amsterdam Stock Exchange: 49AC NOTICE TO THE HOLDERS OF: EUR 200,000,000 EURO FIXED RATE ENHANCED CAPITAL ADVANTAGED PREFERRED SECURITIES ("LP IV ECAPS") ISSUER: LEHMAN BROTHERS UK CAPITAL FUNDING IV LP ("LP IV") ISIN: XS0282978666 LIQUIDATION OF LB GP NO.1 LTD ("the Company") AND IMPLICATIONS FOR HOLDERS OF LP IV ECAPS THIS NOTICE CONTAINS IMPORTANT INFORMATION THAT IS OF INTEREST TO THE REGISTERED AND BENEFICIAL OWNERS OF THE SUBJECT SECURITIES. IF APPLICABLE, ALL DEPOSITORIES, CUSTODIANS AND OTHER INTERMEDIARIES RECEIVING THIS NOTICE ARE REQUESTED TO EXPEDITE THE RE-TRANSMITTAL TO BENEFICIAL OWNERS OF THE SECURITIES IN A TIMELY MANNER. Your attention is drawn to the formal notice contained in the PDF link below concerning the Company, LP IV and the LP IV ECAPS. In order to view the formal notice, it is recommended that you copy and paste the link into your browser. http://www.rns-pdf.londonstockexchange.com/rns/8115H_1-2018-11-19.pdf If you

Algeco Announces Third Quarter 2018 Financial Results Conference Call19.11.2018 16:04Pressemelding

LONDON, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Algeco Investments B.V. (together with its subsidiaries, “Algeco”), the leading global business services provider of modular space, secure portable storage solutions and remote workforce accommodations, today announced that it will hold its third quarter 2018 financial results conference call on Monday 26 November 2018 at 3:00pm GMT (10:00 a.m., Eastern Time). To access the call, please dial: UK: +44 3333000804 or 08003589473 (UK toll free) US: +1 6319131422 or +1 855 85 70686 (US toll free) and enter participant PIN code 84969282# approximately ten minutes prior to the start of the call. You will be placed on hold until the event begins. The conference call will also be broadcast over the internet with an accompanying slide presentation. To join the web conference, go to https://event.on24.com/wcc/r/1884864/AA4F091A2F921FE451DDBD688F19B26F. Please enter your name, email address and company to join the call. The customer service team can be rea

Bombardier to supply 19 OMNEO Premium trains for the Hauts-de-France region’s intercity lines19.11.2018 15:31Pressemelding

OMNEO Premium will provide about 25% more seating capacity to intercity travelers between Paris and the Hauts-de-France region A comfortable double-deck train offering new features such as newly-designed spacious seats, easier platform access and ample baggage space BERLIN, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Note to editors: To view the photo associated with this press release, please visit the following link: http://www.globenewswire.com/NewsRoom/AttachmentNg/683009f7-6c0e-4ab2-8800-5bb87399c7e0 Mobility technology leader Bombardier Transportation announced today that it received an order for 19 BOMBARDIER OMNEO Premium double-deck trains from the French National Railway Corporation, Société nationale des chemins de fer français (SNCF) on behalf of the Hauts-de-France region. This call-off order is part of the contract signed in 2010 with SNCF to provide up to 860 double deck-trains to French regions and is valued at approximately 256 million euro ($291 million US), including price esc

CP Kelco Announces Plans to Invest in Specialty Biogums Capabilities and Capacity Expansion19.11.2018 14:15Pressemelding

ATLANTA, Nov. 19, 2018 (GLOBE NEWSWIRE) -- In response to the strong global demand for specialty Biogums products, CP Kelco announced today its plans to invest in building capabilities and expanding production capacity. As a leading global producer and innovator of hydrocolloid solutions, CP Kelco is reinforcing its commitment to three Biogums product lines – gellan gum, specialty xanthan gum and diutan gum – through these key operational initiatives: Adding gellan gum production capabilities in the company’s Wulian, China facility to support growth in the Asia Pacific region; Expanding the overall capacity of the Wulian, China facility to support growth across all three specialty Biogums product lines; and Expanding the recently added gellan gum production capacity in the company’s Okmulgee, Oklahoma, USA facility. In addition to the planned investments in new production capabilities and capacity, CP Kelco is equally committed to ensuring its Biogums products meet the high standards o

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom